About [1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]methylurea
[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]methylurea (PubChem CID 138491609) has the molecular formula C15H17N5O4
and a molecular weight of 331.33 g/mol. Its IUPAC name is [1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]methylurea.
Molecular Properties
| Compound Name | [1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]methylurea |
| PubChem CID | 138491609 |
| Molecular Formula | C15H17N5O4 |
| Molecular Weight | 331.33 g/mol |
| Exact Mass | 331.13 |
| IUPAC Name | [1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]methylurea |
| SMILES | Cn1c(=O)n(C2CCC(=O)NC2=O)c2ccc(CNC(N)=O)cc21 |
| InChI | InChI=1S/C15H17N5O4/c1-19-11-6-8(7-17-14(16)23)2-3-9(11)20(15(19)24)10-4-5-12(21)18-13(10)22/h2-3,6,10H,4-5,7H2,1H3,(H3,16,17,23)(H,18,21,22) |
| InChIKey | JWWNHZKTSXKZFK-UHFFFAOYSA-N |
| XLogP | -0.51 |
| TPSA | 128.22 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 331.33 |
| LogP ≤ 5 | -0.51 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Analyze [1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]methylurea with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of [1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]methylurea?
The IUPAC name of [1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]methylurea (CID 138491609) is [1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]methylurea.
What is the SMILES notation for [1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]methylurea?
The canonical SMILES for [1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]methylurea is Cn1c(=O)n(C2CCC(=O)NC2=O)c2ccc(CNC(N)=O)cc21.
What is the InChIKey of [1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]methylurea?
The InChIKey is JWWNHZKTSXKZFK-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H17N5O4/c1-19-11-6-8(7-17-14(16)23)2-3-9(11)20(15(19)24)10-4-5-12(21)18-13(10)22/h2-3,6,10H,4-5,7H2,1H3,(H3,16,17,23)(H,18,21,22).
What are the key properties of [1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]methylurea?
[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]methylurea has a molecular weight of 331.33 g/mol, XLogP of -0.51, 3 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]methylurea is sourced from PubChem (CID 138491609), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).